Track topics on Twitter Track topics that are important to you
Summit Asset Management LLC lowered its position in shares of Bristol-Myers Squibb Company by 5.1% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission . The firm owned 7,382 shares of the biopharmaceutical company's stock after selling 400 shares during the quarter.NEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...